Abstract is: Posaconazole, sold under the brand name Noxafil among others, is a triazole antifungal medication. It was approved for medical use in the United States in September 2006, and is available as a generic medication.
type of chemical entity | Q113145171 |
azole | Q419639 |
4-[4-[4-[4-[[(5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one | Q56867649 |
P3780 | active ingredient in | Noxafil | Q29006236 |
Posaconazole Sp | Q29006348 | ||
P366 | has use | medication | Q12140 |
P8026 | LiverTox likelihood score | LiverTox toxicity likelihood category E* | Q83284878 |
P2067 | mass | 700.329708 | |
P2175 | medical condition treated | aspergillosis | Q259626 |
P3489 | pregnancy category | Australian pregnancy category B3 | Q3679234 |
US pregnancy category C | Q28123617 | ||
P769 | significant drug interaction | nifedipine | Q39111 |
pimozide | Q144085 | ||
quetiapine | Q408535 | ||
dronedarone | Q408637 | ||
famotidine | Q411159 | ||
alfentanil | Q176533 | ||
lapatinib | Q420323 | ||
lopinavir | Q422585 | ||
ritonavir | Q422618 | ||
saquinavir | Q422654 | ||
vardenafil | Q424161 | ||
disopyramide | Q425120 | ||
ivabradine | Q425729 | ||
nilotinib | Q412327 | ||
sunitinib | Q417542 | ||
sufentanil | Q417915 | ||
ergotamine | Q419186 | ||
panobinostat | Q7131441 | ||
pazopanib | Q7157043 | ||
eliglustat | Q21011224 | ||
dasatinib monohydrate | Q27139135 | ||
domperidone | Q424238 | ||
tolterodine | Q424312 | ||
ranolazine | Q907104 | ||
bedaquiline | Q1257318 | ||
atorvastatin | Q668093 | ||
simvastatin | Q670131 | ||
P2868 | subject has role | antifungal | Q578726 |
bactericide | Q804539 | ||
trypanocidal agent | Q50430185 | ||
14-alpha demethylase inhibitor | Q50430402 |
Q113911947 | A Study of BGB-11417 in Participants With Myeloid Malignancies |
Q61917941 | A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED) |
Q113923076 | Azole-echinocandin Combination Therapy for Invasive Aspergillosis |
Q113918375 | DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia |
Q63592217 | HDM201 Added to CT in R/R or Newly Diagnosed AML |
Q113898932 | Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial |
Q61921701 | POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) |
Q63613411 | Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole |
Q63322408 | Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients |
Q113944991 | Pharmacokinetic of Posaconazole in Critically Ill Patients |
Q63394024 | Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants |
Q63592601 | Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML) |
Q63322254 | Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis |
Q61938181 | Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) |
Q113919468 | Pilot Study of Posaconazole in Crohn's Disease |
Q106138959 | Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127) |
Q62040535 | Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants |
Q63535108 | Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients |
Q113933254 | Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients |
Q113909696 | Posaconazole for Pulmonary Fungal Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Patients |
Q63394807 | Posaconazole vs Itraconazole in Preventing IFD Post-HSCT |
Q63229487 | Registry of Patients Treated With Systemic Mold-Active Triazoles |
Q63813463 | Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML) |
Q93329002 | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation |
Q176533 | alfentanil |
Q668093 | atorvastatin |
Q1257318 | bedaquiline |
Q27139135 | dasatinib monohydrate |
Q425120 | disopyramide |
Q424238 | domperidone |
Q408637 | dronedarone |
Q21011224 | eliglustat |
Q419186 | ergotamine |
Q411159 | famotidine |
Q425729 | ivabradine |
Q420323 | lapatinib |
Q422585 | lopinavir |
Q39111 | nifedipine |
Q412327 | nilotinib |
Q7131441 | panobinostat |
Q7157043 | pazopanib |
Q144085 | pimozide |
Q408535 | quetiapine |
Q907104 | ranolazine |
Q422618 | ritonavir |
Q422654 | saquinavir |
Q670131 | simvastatin |
Q417915 | sufentanil |
Q417542 | sunitinib |
Q424312 | tolterodine |
Q424161 | vardenafil |
Q39653780 | A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy. |
Q38483558 | A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis |
Q61815416 | An atypical cause of sporotrichosis in a cat |
Q35794484 | Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period |
Q45731816 | Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease. |
Q64118615 | Diagnosis of Rhinocerebral Mucormycosis by Treatment of Cavernous Right Internal Carotid Artery Occlusion With Mechanical Thrombectomy: Special Case Presentation and Literature Review |
Q48202863 | Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers |
Q34262150 | Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis |
Q35941465 | Efficacy of posaconazole in murine experimental sporotrichosis |
Q40298087 | Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome |
Q53671069 | Impact of benzodiazepines on posaconazole serum concentrations. A population-based pharmacokinetic study on drug interaction. |
Q42151635 | In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole. |
Q64107228 | Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy |
Q64281494 | Mucor menace in an immunocompetent young male after dental manipulation |
Q36018743 | Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring |
Q37973020 | Posaconazole: the case for therapeutic drug monitoring. |
Q37901534 | Posaconazole: when and how? The clinician's view |
Q93329002 | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation |
Q83575109 | Successful treatment of cutaneous zygomycosis with extensive surgical debridement and oral posaconazole in an immunocompetent patient |
Q64227333 | The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo |
Q37989562 | Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization |
Category:Posaconazole | wikimedia | |
Arabic (ar / Q13955) | بوساكونازول | wikipedia |
azb | پوساکونازول | wikipedia |
Posaconazol | wikipedia | |
Posaconazole | wikipedia | |
Posaconazol | wikipedia | |
Persian (fa / Q9168) | پوساکونازول | wikipedia |
Posaconazole | wikipedia | |
ポサコナゾール | wikipedia | |
or | ପୋସାକୋନାଜୋଲ | wikipedia |
Posaconazol | wikipedia | |
Posaconazol | wikipedia | |
Позаконазол | wikipedia | |
Serbo-Croatian (sh / Q9301) | Posakonazol | wikipedia |
Posakonazol | wikipedia | |
Posakonazol | wikipedia | |
Позаконазол | wikipedia | |
Posaconazole | wikipedia |
Search more.